After the Annual General Meeting, the Board of Directors of Novo Nordisk A/S held a board meeting to appoint members of its committees. The Board of Directors, including its committees, is now composed as follows: · Helge Lund (chair of the Board and chair of the Nomination Committee) · Henrik Poulsen (vice chair of the Board, chair of the Remuneration Committee and member of the Audit Committee) · Elisabeth Dahl Christensen (employee representative and member of the Remuneration Committee) · Laurence Debroux (chair of the Audit Committee and member of the Remuneration Committee) · Andreas Fibig (member of the Research & Development Committee) · Sylvie Grégoire (member of the Audit Committee, the Nomination Committee and the Research & Development Committee) · Liselotte Hyveled (employee representative and member of the Research & Development Committee) · Mette Bøjer Jensen (employee representative and member of the Audit Committee) · Kasim Kutay (member of the Nomination Committee and the Research & Development Committee) · Christina Law (member of the Audit Committee) · Martin Mackay (chair of the Research & Development Committee and member of the Remuneration Committee) · Thomas Rantzau (employee representative and member of the Nomination Committee).